1. Home
  2. EEIQ vs PMCB Comparison

EEIQ vs PMCB Comparison

Compare EEIQ & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EpicQuest Education Group International Limited

EEIQ

EpicQuest Education Group International Limited

N/A

Current Price

$4.12

Market Cap

7.8M

Sector

Real Estate

ML Signal

N/A

Logo PharmaCyte  Biotech Inc.

PMCB

PharmaCyte Biotech Inc.

N/A

Current Price

$0.32

Market Cap

6.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EEIQ
PMCB
Founded
2017
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.8M
6.3M
IPO Year
2019
2001

Fundamental Metrics

Financial Performance
Metric
EEIQ
PMCB
Price
$4.12
$0.32
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
9.1K
★ 65.7K
Earning Date
06-25-2026
12-17-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.15
$0.33
52 Week High
$12.70
$1.51

Technical Indicators

Market Signals
Indicator
EEIQ
PMCB
Relative Strength Index (RSI) 41.32 28.63
Support Level $2.39 N/A
Resistance Level $4.50 $0.40
Average True Range (ATR) 0.17 0.03
MACD -0.12 0.00
Stochastic Oscillator 5.88 2.40

Price Performance

Historical Comparison
EEIQ
PMCB

About EEIQ EpicQuest Education Group International Limited

EpicQuest Education Group International Ltd provides comprehensive education solutions for domestic and international students interested in university and college degree programs in the U.S, Canada, and the UK. In addition, the company has a recruiting relationship with the regional campuses of Miami University of Ohio, where it maintains residential facilities, a full-service cafeteria, recreational facilities, shuttle buses, and an office for the regional campuses that provides study abroad and post-study services for its students; these facilities are not owned, maintained, operated or are part of Miami University. The Company's revenue is derived from foreign education programs, university education programs and student accommodation services.

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a biotechnology company focused on developing cellular therapies for cancer based on its proprietary cellulose-based live cell encapsulation technology, Cell-in-a-Box. The technology is intended to be used as a platform for therapies for several types of cancer, including locally advanced, inoperable pancreatic cancer (LAPC). The current generation of the Company's product candidate is CypCaps. The Company is preparing to commercialize cellular therapies for cancer and advance clinical research and development, including a clinical trial in LAPC using encapsulated live cells. Its candidate therapy involves encapsulating genetically engineered human cells that convert an inactive chemotherapy drug into its active, cancer-killing form.

Share on Social Networks: